Skip to main content Help with accessibility Skip to main navigation

UPADACITINIB prolonged-release tablets (RINVOQ ®▼) for Crohn's disease

CCG Approval Status:

Date Added: 23 - Mar - 2023
Grey

The Cheshire and Merseyside Interim Area Prescribing Group does not currently recommend the prescribing of UPADACITINIB prolonged-release tablets (RINVOQ ®▼) for Crohn's disease.